title: Con: Aprotinin should not be used in cardiac surgery with cardiopulmonary bypass.
authors.affiliation: Department of Anesthesiology and Critical Care, Cardiothoracic and Vascular Section, Hospital of the University of Pennsylvania, Philadelphia, PA 19104-4283, USA. yiandoc@hotmail.com
authors.forename: John G T
authors.initials: JG
authors.lastname: Augoustides
mesh_terms: D007611:Aprotinin / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D016063:Blood Loss, Surgical / Q000517:prevention & control; D001803:Blood Transfusion; D006348:Cardiac Surgical Procedures; D002315:Cardiopulmonary Bypass; D016527:Drug Costs; D006490:Hemostatics / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D006801:Humans; D008239:Lysine / Q000031:analogs & derivatives; D015842:Serine Proteinase Inhibitors / Q000627:therapeutic use
chemical_list: D006490:Hemostatics; D015842:Serine Proteinase Inhibitors; D007611:Aprotinin; D008239:Lysine